147 related articles for article (PubMed ID: 7753037)
1. Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.
Schulte-Bockholt A; Fink JG; Meier DA; Otterson MF; Telford GL; Hopp K; Koch TR
Mol Cell Biochem; 1995 Jan; 142(1):1-7. PubMed ID: 7753037
[TBL] [Abstract][Full Text] [Related]
2. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
3. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
Koch TR; Michener SR; Carney JA; Go VL
Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
[TBL] [Abstract][Full Text] [Related]
4. Colonic vasoactive intestinal polypeptide in ulcerative colitis.
Surrenti C; Renzi D; Garcea MR; Surrenti E; Salvadori G
J Physiol Paris; 1993; 87(5):307-11. PubMed ID: 8298608
[TBL] [Abstract][Full Text] [Related]
5. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.
Kishimoto S; Kobayashi H; Shimizu S; Haruma K; Tamaru T; Kajiyama G; Miyoshi A
Dig Dis Sci; 1992 Nov; 37(11):1729-37. PubMed ID: 1425074
[TBL] [Abstract][Full Text] [Related]
6. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
Koch TR; Carney JA; Go VL
Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
[TBL] [Abstract][Full Text] [Related]
7. Peptidergic nerves in the colon of patients with ulcerative colitis.
Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M
Hepatogastroenterology; 2000; 47(32):400-4. PubMed ID: 10791200
[TBL] [Abstract][Full Text] [Related]
8. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide.
Koch TR; Carney JA; Go L; Go VL
Gastroenterology; 1988 Feb; 94(2):300-10. PubMed ID: 2446945
[TBL] [Abstract][Full Text] [Related]
11. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
Jönsson M; Norrgård O; Forsgren S
Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
[TBL] [Abstract][Full Text] [Related]
12. Decreased vasoactive intestinal peptide levels and glutathione depletion in acquired megacolon.
Koch TR; Schulte-Bockholt A; Otterson MF; Telford GL; Stryker SJ; Ballard T; Opara EC
Dig Dis Sci; 1996 Jul; 41(7):1409-16. PubMed ID: 8689918
[TBL] [Abstract][Full Text] [Related]
13. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
Jönsson M; Norrgård O; Hansson M; Forsgren S
Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
[TBL] [Abstract][Full Text] [Related]
14. Total antioxidant capacity of colon in patients with chronic ulcerative colitis.
Koch TR; Yuan LX; Stryker SJ; Ratliff P; Telford GL; Opara EC
Dig Dis Sci; 2000 Sep; 45(9):1814-9. PubMed ID: 11052325
[TBL] [Abstract][Full Text] [Related]
15. Pannexin-2 is expressed in the human colon with extensive localization in the enteric nervous system.
Diezmos EF; Sandow SL; Perera DS; King DW; Bertrand PP; Liu L
Neurogastroenterol Motil; 2015 May; 27(5):672-83. PubMed ID: 25773474
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of MUC2 synthesis in ulcerative colitis.
Tytgat KM; van der Wal JW; Einerhand AW; Büller HA; Dekker J
Biochem Biophys Res Commun; 1996 Jul; 224(2):397-405. PubMed ID: 8702401
[TBL] [Abstract][Full Text] [Related]
17. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease.
Kubota Y; Petras RE; Ottaway CA; Tubbs RR; Farmer RG; Fiocchi C
Gastroenterology; 1992 Apr; 102(4 Pt 1):1242-51. PubMed ID: 1551531
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin in the idiopathic inflammatory bowel diseases.
Koch TR; Carney JA; Morris VA; Go VL
Dis Colon Rectum; 1988 Mar; 31(3):198-203. PubMed ID: 2894935
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis.
Kawahito Y; Sano H; Mukai S; Asai K; Kimura S; Yamamura Y; Kato H; Chrousos GP; Wilder RL; Kondo M
Gut; 1995 Oct; 37(4):544-51. PubMed ID: 7489943
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of enteral nervous system in children with drug resistant ulcerative colitis].
Kamińska B; Landowski P; Gonkowski S; Szlagatys-Sidorkiewicz A; Majewski M; Dobosz M; Ismail H; Korzon M
Med Wieku Rozwoj; 2007; 11(2 Pt 1):117-22. PubMed ID: 17625279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
